Envoy Medical (NASDAQ:COCHW – Get Free Report) will likely be announcing its results before the market opens on Thursday, November 5th. Analysts expect the company to post earnings of ($0.6733) per share and revenue of $0.09 million for the quarter.
Envoy Medical Stock Performance
NASDAQ:COCHW traded up $0.00 during trading hours on Wednesday, reaching $0.03. The company’s stock had a trading volume of 333 shares, compared to its average volume of 25,694. Envoy Medical has a 12 month low of $0.02 and a 12 month high of $0.10. The stock has a 50 day moving average price of $0.04 and a two-hundred day moving average price of $0.05.
Envoy Medical Company Profile
Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with hearing loss. The company’s technologies are designed to use the body’s natural anatomy to capture sound and deliver auditory stimulation, with the goal of providing hearing restoration without the external components required by many conventional hearing devices.
Envoy Medical’s lead product is the Acclaim cochlear implant, a fully implanted device intended for adults with sensorineural hearing loss who may benefit from cochlear implantation.
Featured Articles
- Five stocks we like better than Envoy Medical
- Advanced Micro Devices’ Q3 Results Answer a Big Question, But Another Remains
- High Voltage Returns: Talen Energy Powers the Data Center Rush
- 3 Dividend Increases Above 10%, But Which Offers the Most Income?
- Meta’s $100 Billion AI Financing Plan Has a Catch for Existing Shareholders
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
